📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity. (2021)

First Author: Lim WF

Attributed to: Antisense Oligonucleotide Therapy for Neuromuscular Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/sciadv.abi6896

PubMed Identifier: 34417184

Publication URI: http://europepmc.org/abstract/MED/34417184

Type: Journal Article/Review

Volume: 7

Parent Publication: Science advances

Issue: 34

ISSN: 2375-2548